MC
MNTA

Miles Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Miles Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,808
Closed -$142K – 176
2014
Q4 		$142K Sell
11,808
-535
-4% -$6.11K 0.08% 130
2014
Q3 		$140K Hold
12,343
– – 0.07% 113
2014
Q2 		$149K Buy
+12,343
New +$146K 0.08% 112

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Miles Capital's MNTA Position: Q1 2015 in Review

Miles Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2015, closing a stake of 11,808 shares — an estimated $142K sold.

Miles Capital first reported a position in MNTA in Q2 2014 and held it in 3 quarters. The position peaked at $149K in Q2 2014. 143 funds tracked by Wall St. Rank hold MNTA as of Q1 2015.

  • Miles Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Miles Capital sold 11,808 Momenta Pharmaceuticals, Inc. shares in Q1 2015, an estimated $142K.
  • Miles Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
  • Miles Capital's Momenta Pharmaceuticals, Inc. position peaked at $149K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2015.

Based on Miles Capital's 13F filing for Q1 2015, filed 12 May 2015.